Acro Biomedical Co., Ltd. (ACBM) Research

Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.

Market snapshot

Symbol
ACBM
Price
$0.03
Day change
0.00%
Market cap
$1.6M
P/E ratio
-11.60x
52-week range
0.0007-0.1
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Amarantus BioScience Holdings, Inc. (AMBS)
  • Baseline Productions, Inc. (BSSP)
  • Health Discovery Corporation (HDVY)
  • iBX Group, Inc. (IBXG)
  • Interactive Health Network (IGRW)
  • Itoco Inc. (ITMC)
  • Molecular Pharmacology (USA), Ltd. (MLPH)
  • Naturally Splendid Enterprises Ltd. (NSPDF)

Open Acro Biomedical Co., Ltd. (ACBM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.